JP4464534B2 - 破砕赤血球の測定方法 - Google Patents
破砕赤血球の測定方法 Download PDFInfo
- Publication number
- JP4464534B2 JP4464534B2 JP2000184853A JP2000184853A JP4464534B2 JP 4464534 B2 JP4464534 B2 JP 4464534B2 JP 2000184853 A JP2000184853 A JP 2000184853A JP 2000184853 A JP2000184853 A JP 2000184853A JP 4464534 B2 JP4464534 B2 JP 4464534B2
- Authority
- JP
- Japan
- Prior art keywords
- red blood
- blood cell
- particles
- disrupted
- measuring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000003743 erythrocyte Anatomy 0.000 title claims description 72
- 238000000034 method Methods 0.000 title claims description 26
- 239000002245 particle Substances 0.000 claims description 38
- 210000004369 blood Anatomy 0.000 claims description 14
- 239000008280 blood Substances 0.000 claims description 14
- 238000005259 measurement Methods 0.000 claims description 13
- 210000004027 cell Anatomy 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 239000007850 fluorescent dye Substances 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 238000004820 blood count Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000010186 staining Methods 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 32
- 230000000007 visual effect Effects 0.000 description 14
- 210000000601 blood cell Anatomy 0.000 description 9
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 7
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 210000001995 reticulocyte Anatomy 0.000 description 6
- 229920002477 rna polymer Polymers 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 208000034841 Thrombotic Microangiopathies Diseases 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 239000012192 staining solution Substances 0.000 description 3
- 238000011179 visual inspection Methods 0.000 description 3
- 208000037157 Azotemia Diseases 0.000 description 2
- 208000032759 Hemolytic-Uremic Syndrome Diseases 0.000 description 2
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 238000010322 bone marrow transplantation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 238000007427 paired t-test Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 208000009852 uremia Diseases 0.000 description 2
- 208000004652 Cardiovascular Abnormalities Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000035185 Hemolytic Congenital Anemia Diseases 0.000 description 1
- 206010060893 Hereditary haemolytic anaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000208822 Lactuca Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 206010027540 Microcytosis Diseases 0.000 description 1
- 241001483078 Phyto Species 0.000 description 1
- 201000007023 Thrombotic Thrombocytopenic Purpura Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- JPIYZTWMUGTEHX-UHFFFAOYSA-N auramine O free base Chemical compound C1=CC(N(C)C)=CC=C1C(=N)C1=CC=C(N(C)C)C=C1 JPIYZTWMUGTEHX-UHFFFAOYSA-N 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 201000001516 congenital hemolytic anemia Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 208000024987 familial hemolytic anemia Diseases 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- CIYKWVNUXJDNNK-UHFFFAOYSA-N oxazine-750 Chemical compound N1=C2C3=CC=CC=C3C(NCC)=CC2=[O+]C2=C1C=C1CCCN3CCCC2=C13 CIYKWVNUXJDNNK-UHFFFAOYSA-N 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 description 1
- -1 thiolarabine T Chemical compound 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/012—Red blood cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000184853A JP4464534B2 (ja) | 2000-06-20 | 2000-06-20 | 破砕赤血球の測定方法 |
| US09/801,642 US6670191B2 (en) | 2000-06-20 | 2001-03-09 | Method for quantitatively analyzing fragmented red blood cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000184853A JP4464534B2 (ja) | 2000-06-20 | 2000-06-20 | 破砕赤血球の測定方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002005925A JP2002005925A (ja) | 2002-01-09 |
| JP2002005925A5 JP2002005925A5 (https=) | 2007-06-28 |
| JP4464534B2 true JP4464534B2 (ja) | 2010-05-19 |
Family
ID=18685247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000184853A Expired - Fee Related JP4464534B2 (ja) | 2000-06-20 | 2000-06-20 | 破砕赤血球の測定方法 |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US6670191B2 (https=) |
| JP (1) | JP4464534B2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7405082B2 (en) * | 2002-09-10 | 2008-07-29 | Sysmex Corporation | Methods and devices for measuring reticulocytes |
| GB2399876B (en) * | 2003-03-27 | 2005-12-21 | Michael Catt | Method of investigating a blood sample |
| JP4417143B2 (ja) * | 2004-03-11 | 2010-02-17 | シスメックス株式会社 | 試料分析装置、プログラムおよびそのプログラムを記録した記録媒体 |
| EP2012120B1 (en) * | 2006-04-21 | 2014-03-12 | Nihon Kohden Corporation | Method of classifying particles and apparatus therefor |
| JP5667079B2 (ja) * | 2008-12-18 | 2015-02-12 | アズビル株式会社 | 粒径及び蛍光の同時検出のための小型検出器 |
| US20130098163A1 (en) * | 2010-01-20 | 2013-04-25 | Blaze Medical Devices, LLC | Erythrocyte mechanical fragility tester using disposable cartridges |
| US20110300574A1 (en) * | 2009-01-21 | 2011-12-08 | Michael Tarasev | Cell-counting method for blood hemolysis analysis in fragility measurement |
| JP5351585B2 (ja) * | 2009-03-31 | 2013-11-27 | シスメックス株式会社 | 腎疾患診断支援装置およびコンピュータプログラム |
| CN103439257A (zh) * | 2013-08-15 | 2013-12-11 | 吉林大学 | 样品信息采集装置和方法 |
| WO2018148946A1 (zh) | 2017-02-17 | 2018-08-23 | 深圳迈瑞生物医疗电子股份有限公司 | 红细胞碎片识别方法和装置、血液细胞分析仪及分析方法 |
| CN109270281A (zh) * | 2017-07-18 | 2019-01-25 | 深圳市帝迈生物技术有限公司 | 提高白细胞分类结果准确性和计数结果重复性的方法及设备 |
| CN111602046B (zh) * | 2018-04-28 | 2024-01-09 | 深圳迈瑞生物医疗电子股份有限公司 | 一种血液分析仪及分析方法 |
| CN111684264B (zh) | 2018-04-28 | 2023-05-23 | 深圳迈瑞生物医疗电子股份有限公司 | 血液分析方法、血液分析系统及存储介质 |
| US12584902B2 (en) | 2023-12-10 | 2026-03-24 | Instrumentation Laboratory Company | Acoustic separation of a test sample |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2927979B2 (ja) * | 1991-02-22 | 1999-07-28 | シスメックス株式会社 | フローサイトメトリーによる赤芽球の分類方法 |
| US5858667A (en) * | 1996-09-06 | 1999-01-12 | Litron Laboratories | Method for the enumeration of micronucleated erythrocyte populations with a single laser flow cytometer |
| US6133995A (en) * | 1997-05-09 | 2000-10-17 | Sysmex Corporation | Particle measuring apparatus |
| JP3867880B2 (ja) * | 1998-04-08 | 2007-01-17 | シスメックス株式会社 | 尿中赤血球の鑑別装置および方法 |
| JP4101994B2 (ja) * | 1999-01-21 | 2008-06-18 | シスメックス株式会社 | 粒子分析装置および自動粒子分析方法 |
-
2000
- 2000-06-20 JP JP2000184853A patent/JP4464534B2/ja not_active Expired - Fee Related
-
2001
- 2001-03-09 US US09/801,642 patent/US6670191B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002005925A (ja) | 2002-01-09 |
| US6670191B2 (en) | 2003-12-30 |
| US20010053551A1 (en) | 2001-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3048260B2 (ja) | 白血球分類計数用試料調製方法 | |
| JP4464534B2 (ja) | 破砕赤血球の測定方法 | |
| US8017078B2 (en) | Blood cell analyzer, blood cell analyzing method, and computer program product | |
| JP3707620B2 (ja) | 光散乱技術を使用した網赤血球分析方法と装置 | |
| US5434081A (en) | Method of classifying leukocytes by flow cytometry | |
| JP4101994B2 (ja) | 粒子分析装置および自動粒子分析方法 | |
| US4336029A (en) | Method and reagents for quantitative determination of reticulocytes and platelets in whole blood | |
| US5693484A (en) | Method of classifying and counting cells in urine | |
| JP5762523B2 (ja) | 血液サンプルを分析するための方法およびシステム | |
| Bayliss et al. | Detecting fetomaternal hemorrhage: a comparison of five methods | |
| EP0268766A2 (en) | Method of classifying leukocytes by flow cytometry and reagents used in the method | |
| US20250237644A1 (en) | Bone marrow fluid analysis method, sample analyzer, and non-transitory storage medium | |
| JP3867880B2 (ja) | 尿中赤血球の鑑別装置および方法 | |
| EP4134675A1 (en) | Method for measuring blood coagulation time | |
| JP3467340B2 (ja) | 尿中赤血球の鑑別装置 | |
| EP3410114B1 (en) | Urine analyzer and urinanalysis method | |
| EP0259833B1 (en) | Reagent and method for classifying leukocytes by flow cytometry | |
| WO2021157711A1 (en) | Particle analysis method and particle analyzer | |
| Jarujareet et al. | Classification of beta-thalassemia major and HbE/beta-thalassemia via deep learning of image structure function image | |
| Gunawardena et al. | Comparison of Automated and Manual Reticulocyte Count in a cohort of patient's samples in Haematology Laboratory of Colombo South Teaching Hospital, Sri Lanka | |
| CN119757774B (zh) | 一种医学检验中血液细胞检验的质量控制方法 | |
| JP2024095228A5 (https=) | ||
| Farsinejad | Optimized method for reticulocyte counting: Simple, accurate, and comparable to flow cytometry | |
| JPH10267827A (ja) | 粒子凝集測定装置 | |
| JP4417936B2 (ja) | 尿中赤血球の鑑別装置および方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070514 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070514 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090731 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090804 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100202 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100219 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130226 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4464534 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160226 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |